Delivery Order SPE2DB20D3303-SPE2DB25FZ0F1

Award Date 2/5/25
Potential Completion Date 2/6/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,703.98 firm fixed price contract is for the supply of BREYNA 80-4.5 MCG INHALER 10.3GM medical supplies. The contract has an ultimate completion date of January 2, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,998.50, is a delivery order for the supply of a specific pharmaceutical product, the BREYNA 160-4.5 MCG INHALER 10.3GM. The contract has an ultimate completion date of January 28, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,694.03, is for the procurement of BREYNA 160-4.5 MCG INHALER 10.3GM, a medical product. The contract has an ultimate completion date of January 16, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,693.99, is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM medical supplies. The contract has a completion date of January 22, 2025 and is a Firm Fixed Price contract. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,289.08, is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM medical supplies. The contract has an ultimate completion date of January 21, 2025 and is a firm fixed-price agreement. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of a pharmaceutical product, specifically the BREYNA 160-4.5 MCG INHALER 10.3GM. The contract has a firm fixed price of $2,925.48 and a completion date of September 25, 2024. The contract is not set aside for a specific business category. As one of the largest pharmaceutical distributors in the U.S., AmerisourceBergen leverages its extensive supply chain to provide...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,605.83 firm-fixed-price delivery order contract is for the supply of a BREYNA 160-4.5 MCG INHALER 10.3GM medical product, with an ultimate completion date of November 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract has a ceiling value of $2,535.26 and is for the delivery of the pharmaceutical product "BREYNA 160-4.5 MCG INHALER 10.3GM." The contract does not have a set-aside designation and is scheduled to be completed by April 1, 2024....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567152308 BREYNA 160-4.5 MCG INHALER 10.3GM, a pharmaceutical product, with a ceiling value of $11,669.44. The contract is a firm fixed price delivery order, with an ultimate completion date of February 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,830.39 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of a specific pharmaceutical product, the BREYNA 160-4.5 MCG INHALER 10.3GM, which is a prescription medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB25FZ0F1
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,478.69, is for the supply of a specific pharmaceutical product, the BREYNA 80-4.5 MCG INHALER 10.3GM. The contract has an ultimate completion date of February 6, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/7/25, 9:55 AM